John Didsbury
Directeur Général chez T3D Therapeutics, Inc.
Profil
John Didsbury is currently the Chairman, President & Chief Executive Officer at T3D Therapeutics, Inc. He was previously the President & Chief Executive Officer at Nuada Pharmaceuticals, Inc. from 2000 to 2005, the Chief Scientific Officer at DARA BioSciences, Inc. from 2005 to 2008, the Head-Strategy & Operations Drug Discovery at GlaxoSmithKline, Inc. from 1995 to 2002, and the President, Chief Operating & Scientific Officer at DARA BioSciences, Inc. from 2008 to 2009.
Dr. Didsbury received his undergraduate degree from the University of Connecticut in 1977 and his doctorate degree from the University of Vermont in 1982.
Postes actifs de John Didsbury
Sociétés | Poste | Début |
---|---|---|
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | Directeur Général | 01/01/2013 |
Anciens postes connus de John Didsbury
Sociétés | Poste | Fin |
---|---|---|
DARA BIOSCIENCES INC | President | 06/02/2009 |
DARA BioSciences, Inc. /Old/
DARA BioSciences, Inc. /Old/ Pharmaceuticals: MajorHealth Technology DARA BioSciences, Inc. develops therapeutic and medical technologies and devices. It also provides treatment for metabolic diseases and central nervous system disorders . The company was founded by Steve Gorlin in July, 2002 and is headquartered in Raleigh, NC. | Directeur Technique/Scientifique/R&D | 12/02/2008 |
Nuada Pharmaceuticals, Inc.
Nuada Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuada Pharmaceuticals, Inc. operates as a pharmaceutical company. The private company is based in Durham, NC. | President | 01/01/2005 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 01/01/2002 |
Formation de John Didsbury
University of Connecticut | Undergraduate Degree |
University of Vermont | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 5 |
---|---|
DARA BioSciences, Inc. /Old/
DARA BioSciences, Inc. /Old/ Pharmaceuticals: MajorHealth Technology DARA BioSciences, Inc. develops therapeutic and medical technologies and devices. It also provides treatment for metabolic diseases and central nervous system disorders . The company was founded by Steve Gorlin in July, 2002 and is headquartered in Raleigh, NC. | Health Technology |
DARA BioSciences, Inc.
DARA BioSciences, Inc. Pharmaceuticals: MajorHealth Technology DARA BioSciences, Inc. is a pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care products. The company's product portfolio includes Soltamox, Gelclair, Bionect and KRN5500. Soltamox offers a choice to patients who prefer or need a liquid form of tamoxifen. Gelclair is an alcohol-free bioadherent oral rinse gel for rapid and effective relief of pain associated with oral mucositis caused by chemotherapy and radiation treatment. The company markets Bionect, a topical treatment for skin irritation and burns associated with radiation therapy, in U.S. oncology/radiology markets. DARA BioSciences was founded by Steven Gorlin on June 22, 2002 and is headquartered in Raleigh, NC. | Health Technology |
Nuada Pharmaceuticals, Inc.
Nuada Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuada Pharmaceuticals, Inc. operates as a pharmaceutical company. The private company is based in Durham, NC. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | Health Technology |